EPTAM Precision, Sterling join forces

EPTAM Precision Solutions, a Frazier Healthcare Partners portfolio company, acquired Sterling Manufacturing and its wholly owned subsidiary Albright Silicone. Sterling is a component manufacturer headquartered in Lancaster, Massachusetts specializing in plastic injection molding and liquid silicone rubber (LSR) molding serving the medical device, molecular diagnostics, biopharma, consumer electronics and aerospace & defense markets.

In addition to further bolstering EPTAM’s presence in the life sciences, biopharma, and broader medical device market, the transaction expands and further diversifies EPTAM’s capabilities, offering customers a single partner of choice to solve their plastics manufacturing requirements. Albright brings an exciting new capability into the EPTAM portfolio with their expertise in silicone injection tooling fabrication and molding. With Albright sitting only minutes down the road in Leominster, MA, the combined molding expertise of Sterling and Albright will allow EPTAM to serve as a one-stop shop for medical customers requiring both thermoplastic and LSR injection molded components.

Founded in 1981, EPTAM is an outsourced manufacturer of medical device components, implants, single-use medical disposable, biopharma and diagnostic devices, as well as other high-precision surgical device components. The Company has expertise with polymer machining, precision metal machining, injection molding, laser cutting/welding and metal injection molding, which the company targets to open later this year. Additionally, EPTAM offers a wide range of value-added services such as process validation, design-for-assembly, cleanroom assembly, laser cutting/welding equipment and process development, rapid-prototyping, and technical program management solutions. EPTAM has more than 500 employees with operations in New Hampshire, Colorado, New Jersey, Minnesota, Connecticut, and Michigan.

EPTAM’s CEO, Mark Kemp says, “By welcoming the professionals from Sterling and Albright to our team, EPTAM adds world-class, highly automated, thermoplastic and liquid silicone rubber injection molding expertise, while also expanding our front-end engineering support offering and benefitting from Sterling’s proximity to many of the leading molecular diagnostic and biopharma OEMs located in the greater New England area.”

Stan Bowker, president of Sterling, says, “We are excited to be joining the EPTAM family. They share the same culture and values, creating the ideal partnership for our next chapter. EPTAM’s reach and industry expertise, especially in the MedTech space, combined with our world class molding, tooling, and automation experience, will greatly enhance our capabilities and offerings to our customers.”

John Gravelle, CEO of Sterling, complements, “Partnering with EPTAM is a great opportunity in the evolution of Sterling’s capabilities. We are confident this acquisition will expand EPTAM’s vast technical capabilities in servicing the life sciences and medical markets. We could not have found a better strategic fit.”